Industry NewsOxford University researchers target previously unknown ‘genetic vulnerability’ in breast cancer cells
Product NewsEvaluate convalescent plasma, antibody therapies, and vaccines for COVID-19 with Leinco Technologies’ novel ELISA kit
Product NewsBest-in-class solutions for COVID-19 diagnosis, surveillance, and therapeutic development
Product NewsFirst FDA Approved CDx for RET fusion-positive metastatic non-small cell lung cancer (NSCLC)
Expert InsightsAll antibodies are NOT created equal: Comprehensive profiling of SARS-CoV-2 antibodies